Rahul Mohindar, Director of viratechindia.com is of the view that, in midcap space, Glenmark Pharma has fairly good potential. The stock is expected to rally to Rs 490.
first published: Nov 22, 2012 02:40 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

